The 2010 cosmetic surgery market is worth USD1 billion dollars in the States.
The market for cosmetic surgery and laser procedures is anticipated to nearly double in size and pass the USD3 billion in the next seven years, so says iData Research, a pharmaceutical market research firm, Vancouver.
The iData report estimates the market for aesthetic botulinum toxin A drugs, like, Botox is going to grow to an estimated USD543 million by 2017, with the aesthetic light and laser therapy markets for skin resurfacing, laser lipolysis and hair removal being the quickest-growing segments.
The American market for aesthetic facial injectable products is currently valued at almost USD860 million.
Many doctors in the States are considering the therapeutic potential of botulinum A, with increasingly more cosmetic procedures being performed using botulinum A.